- Home
- BMO vs GSK Comparison
BMO vs GSK Comparison
Compare BMO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMO
- GSK
- Stock Information
- Founded
- BMO 1817
- GSK 1715
- Country
- BMO Canada
- GSK United Kingdom
- Employees
- BMO N/A
- GSK N/A
- Industry
- BMO Commercial Banks
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- BMO Finance
- GSK Health Care
- Exchange
- BMO Nasdaq
- GSK Nasdaq
- Market Cap
- BMO 67.8B
- GSK 71.7B
- IPO Year
- BMO N/A
- GSK N/A
- Fundamental
- Price
- BMO $93.43
- GSK $35.93
- Analyst Decision
- BMO Hold
- GSK Hold
- Analyst Count
- BMO 5
- GSK 4
- Target Price
- BMO $128.40
- GSK $47.00
- AVG Volume (30 Days)
- BMO 749.5K
- GSK 6.0M
- Earning Date
- BMO 05-28-2025
- GSK 04-30-2025
- Dividend Yield
- BMO 4.80%
- GSK 4.32%
- EPS Growth
- BMO 45.17
- GSK N/A
- EPS
- BMO 7.33
- GSK 0.78
- Revenue
- BMO $20,896,698,023.00
- GSK $39,280,393,592.00
- Revenue This Year
- BMO $25.09
- GSK $7.60
- Revenue Next Year
- BMO $3.90
- GSK $5.24
- P/E Ratio
- BMO $12.67
- GSK $22.27
- Revenue Growth
- BMO 3.42
- GSK 3.46
- 52 Week Low
- BMO $76.98
- GSK $31.72
- 52 Week High
- BMO $106.00
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- BMO 47.67
- GSK 45.54
- Support Level
- BMO $91.77
- GSK $32.38
- Resistance Level
- BMO $93.50
- GSK $36.16
- Average True Range (ATR)
- BMO 2.94
- GSK 1.16
- MACD
- BMO 0.23
- GSK -0.13
- Stochastic Oscillator
- BMO 63.83
- GSK 52.28
About BMO Bank Of Montreal
Bank of Montreal is a diversified financial-services provider based in North America with over CAD 1.4 trillion in assets. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.